Free
Education  |   January 2003
Effects of Preemptive Analgesia on Pain and Cytokine Production in the Postoperative Period
Author Affiliations & Notes
  • Benzion Beilin, M.D.
    *
  • Hanna Bessler, Ph.D.
  • Eduard Mayburd, M.D.
  • Genady Smirnov, M.D.
    §
  • Arie Dekel, M.D.
  • Israel Yardeni, M.D.
    #
  • Yehuda Shavit, Ph.D.
    **
  • *Senior Lecturer of Anesthesiology and Chair, ‡Resident of Anesthesiology, §Resident of Anesthesiology, #Instructor of Anesthesiology, Department of Anesthesiology, †Senior Lecturer of Immunology, Research Institute, ∥Lecturer of Obstetrics and Gynecology, Department of Gynecology, Rabin Medical Center, Golda-Hasharon Campus, Petah Tiqva, affiliated with the Sackler School of Medicine, Tel-Aviv University. **Associate Professor of Psychology and Chair, Department of Psychology, Hebrew University, Jerusalem, Israel.
Article Information
Education
Education   |   January 2003
Effects of Preemptive Analgesia on Pain and Cytokine Production in the Postoperative Period
Anesthesiology 1 2003, Vol.98, 151-155. doi:0000542-200301000-00024
Anesthesiology 1 2003, Vol.98, 151-155. doi:0000542-200301000-00024
PAIN management remains a major concern in the postoperative period. Pain affects various systems, including cardiac, pulmonary, and metabolic, and thus, it may affect surgical outcome. 1 Although it has been shown in animal studies that pain can contribute to postoperative immune suppression, 2 little clinical evidence is available showing the effects of postoperative pain management on the immune response.
We have recently examined the effects of three postoperative pain management techniques on the immune response in patients undergoing abdominal surgery (submitted for publication). Patients were randomly assigned to one of three postoperative pain management techniques: systemic administration of opiates on intermittent regimen, patient-controlled analgesia, and patient-controlled epidural analgesia (PCEA). In the immediate postoperative period, patients of the PCEA group exhibited reduced postoperative pain, reduced suppression of lymphocyte mitogenic response, and attenuated proinflammatory cytokine response.
Preemptive analgesia is a commonly used pain management technique in which analgesic treatment begins prior to the surgical incision. Preemptive analgesia, continued into the postoperative period, can reduce both the incisional and inflammatory pain and in this way can reduce peripheral and central sensitization. 3 Although the beneficial effects of preemptive analgesia have been demonstrated in animal studies, the clinical value of this technique remains indecisive because of methodological problems, flaws in the design of clinical studies, and lack of objective measures. 4 
Extending our previous findings, the present study sought to examine whether preemptive analgesia continued with PCEA may attenuate proinflammatory cytokine production in the postoperative period. We also examined the effects of preemptive analgesia on the production of antiinflammatory cytokines and on interleukin (IL)-2. The present study compared ex vivo  cytokine production in two groups of patients, one receiving PCEA, the other receiving preemptive epidural analgesia continued in the postoperative period with PCEA.
Materials and Methods
Patients
Healthy female patients (American Society of Anesthesiologists physical status I or II) aged 40–70 yr old were included in this study after obtaining approval from the Hospital Human Studies Committee and informed consent from the patients. Patients were hospitalized to undergo transabdominal hysterectomy (for details, see table 1). On the preoperative visit by the anesthesiologist, patients were randomly assigned to one of two perioperative pain management techniques (treatment lasted until 48 h postoperatively): One group (N = 20) received PCEA in the postoperative period; the other (N = 21) received preemptive epidural followed by PCEA (PA + PCEA). On the same visit, patients were familiarized with the visual analog pain scale (VAS) and were instructed on the use of the PCEA pump.
Table 1. Characteristics of Patients According to Postoperative Pain Management Group
Image not available
Table 1. Characteristics of Patients According to Postoperative Pain Management Group
×
Anesthesia
Patients were premedicated with lorazepam (1–2 mg orally) 90 min before induction of anesthesia, followed by 2–3 mg intravenous midazolam on arrival in the operating theater. An epidural catheter was placed in all patients via  the L2–L4 interspaces and was advanced 3 to 4 cm cephalad. The position of the epidural catheter was tested with 3 ml lidocaine, 2%. Patients of the PA + PCEA group received an epidural mixture of 12 ml bupivacaine (0.5%) plus fentanyl (50–100 μg) 20–25 min before incision.
General anesthesia was induced using 2–3 μg/kg fentanyl, 4–6 mg/kg thiopental, and 0.1 mg/kg vecuronium, intravenously. Anesthesia was maintained with nitrous oxide, isoflurane, and additional fentanyl. Mean arterial blood pressure was maintained within 20% of baseline values with isoflurane and fentanyl. Patients received upper body forced-air warming, and intravenous fluids were warmed to 37°C. Patients requiring blood transfusion during the perioperative period were not included in this study.
Postoperative Pain Management
On arrival to the postanesthesia care unit, patients of both groups were connected to the PCEA pump (Pain Management Provider; Abbott, Chicago, IL) and received 3 ml bupivacaine (0.1%) plus 2 μg/ml fentanyl per demand (lockout time, 10 min), with continuous background infusion of 6 ml/h.
A 10-cm VAS (with end points labeled “no pain” and “worst possible pain”) was used to assess pain intensity in rest and after coughing at 4, 8, 12, 24, 48, and 72 h after completion of surgery.
Immunologic Assays
Venous blood samples (15 ml) were collected on the morning of the surgery and at 24, 48, and 72 h following surgery. Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized venous blood using a histopaque (Sigma-Aldrich, Rehovot, Israel) gradient centrifugation. PBMCs were washed twice in RPMI-1640 medium containing 1% penicillin, streptomycin, and nystatin and supplemented with 10% fetal calf serum (designated complete medium). Cells were suspended in fetal calf serum containing 10% dimethyl sulfoxide (Sigma) and were frozen at −70°C until used. On the day of assay, cells were thawed quickly and washed three times in complete medium, and their viability was tested by trypan blue dye exclusion. The viability was over 95%.
Cytokine (IL-1β, IL-2, IL-6, IL-10, IL-1ra, and TNF-α) Production
Peripheral blood mononuclear cells (2 × 106) suspended in 1 ml RPMI-1640 supplemented with 5% fetal calf serum were incubated for 24 h in the presence of 10 ng/ml lipopolysaccharide (E. coli  ; Sigma-Aldrich) for IL-1β, IL-1ra, IL-6, IL-10, and tumor necrosis factor (TNF)-α. For IL-2 production, 2 × 106PBMCs were suspended in 1 ml complete medium and were incubated for 48 h with 1% phytohemagglutinin (PHA-M; Difco Laboratories, Detroit, MI). Following the incubation period, culture media were collected, cells were removed by centrifugation, and the supernatants were kept at −70°C until assayed for cytokine content.
Cytokine concentration in the supernatant was assessed using ELISA kits specific for human IL-1β, IL-1ra (Biosource International, Camarillo, CA), IL-6, (Pharmingen, San Diego, CA), IL-2 (R&D Systems, Minneapolis, MN), and IL-10 (Genzyme Corporation, Cambridge, MA), as detailed in the guidelines provided by the manufacturers. The detection levels of the cytokines in the assays were 30 pg/ml for IL-1β and IL-2, 15 pg/ml for IL-6, and 60 pg/ml for IL-1ra and TNF-α.
Statistical Analysis
The number of observations varies slightly among assays as a result of an occasional missing sample or an occasional problem in a particular assay. Data were analyzed for each measure, using analysis of variance with repeated measures (time periods before and after surgery). 5 A post hoc  Bonferroni procedure was conducted as appropriate, correcting for multiple comparisons. 5 Probability values of P  < 0.05 were considered significant. The results are expressed as mean ± SEM.
Results
The groups were similar in body weight, age, duration of surgery, and total fentanyl consumption in 48 h postoperatively (table 1).
Postoperative Pain
Pain scores reveal similar trends between the measures taken at rest or during coughing. There were significant differences among the study groups (F1,39= 20.71 or 23.67;P  < 0.0001 for VAS at rest or VAS during coughing, respectively;figs. 1A and B). Patients of the PA + PCEA group experienced less severe postoperative pain throughout the postoperative observation period.
Fig. 1. Visual analog scale (VAS) pain scores at rest (A  ) and during coughing (B  ) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
Fig. 1. Visual analog scale (VAS) pain scores at rest (A 
	) and during coughing (B 
	) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
Fig. 1. Visual analog scale (VAS) pain scores at rest (A  ) and during coughing (B  ) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
×
Ex Vivo  Cytokine Production
Analysis of variance with repeated measures for IL-1β levels revealed significant main effects of groups (PCEA vs.  PA + PCEA; F1,39= 13.63, P  < 0.001) and trials (preoperative, 24, 48, and 72 h postoperative; F3,117= 6.08, P  < 0.001). There was also a significant interaction (group × trial; F3,117= 3.11, P  < 0.03). The analysis of variance test for IL-6 revealed significant main effects of groups (F1,39= 4.25, P  < 0.05) and trials (F3,117= 9.72, P  < 0.001), and significant interaction (group × trial; F3,117= 2.89, P  < 0.04). These results indicate that proinflammatory cytokine production by stimulated PBMCs was elevated in the postoperative period and that such elevation was significantly less pronounced in patients of the PA + PCEA group compared with patients of the PCEA group for both IL-1β and IL-6 (figs. 2A and B, respectively). Levels of TNF-α exhibited a similar trend, which was not statistically significant (fig. 2C). It is known that the maximal release of TNF-α by lipopolysaccharide-stimulated PBMCs occurs earlier than 24 h. This may account for the lack of significant group differences at the times observed in the present study.
Fig. 2. Production of interleukin (IL)-1β (A  ), IL-6 (B  ), and tumor necrosis factor (TNF) α (C  ) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 2. Production of interleukin (IL)-1β (A 
	), IL-6 (B 
	), and tumor necrosis factor (TNF) α (C 
	) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 2. Production of interleukin (IL)-1β (A  ), IL-6 (B  ), and tumor necrosis factor (TNF) α (C  ) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Ex vivo  production of antiinflammatory cytokines was also assessed by stimulated PBMCs. IL-10 and IL-1ra levels were elevated in the postoperative period (significant trial effects in both groups), but this elevation was significantly less pronounced in patients of the PA + PCEA group (group effects: F1,38= 6.16, P  < 0.02 and F1,36= 5.22, P  < 0.03, respectively;figs. 3A and B). The IL-1ra/IL-1β ratio exhibited a slight, but not significant, linear increase from the preoperative to the 72 h postoperative measures (0.74–1.23). There were no significant main effects or a significant interaction. That is, the two groups did not differ in the IL-1ra/IL-1β ratio at any time point (data not shown).
Fig. 3. Production of interleukin (IL)-10 (A  ) and IL-1ra (B  ) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 3. Production of interleukin (IL)-10 (A 
	) and IL-1ra (B 
	) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 3. Production of interleukin (IL)-10 (A  ) and IL-1ra (B  ) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Ex vivo  IL-2 production was assessed in PHA-stimulated PBMCs. There was a significant trial effect (F3,117= 6.18, P  < 0.001), indicating a significant suppression of IL-2 levels in 24 and 48 h postoperatively, examined over the two study groups. There was a significant difference between the study groups in IL-2 levels (F1,39= 5.41, P  < 0.025;fig. 4). IL-2 levels remained almost unchanged in the PA + PCEA group, while they were significantly suppressed in the PCEA group in the first 48 h postoperatively, gradually recovering by 72 h.
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Discussion
Patients of the PA + PCEA group exhibited less severe postoperative pain, compared to the PCEA group. Ex vivo  stimulated PBMCs of these patients produced less elevated levels of both proinflammatory and antiinflammatory cytokines in the postoperative period. In addition, production of IL-2 by stimulated PBMCs was significantly less suppressed in the PA + PCEA group compared to the PCEA group. The findings of increased production of proinflammatory cytokines and suppressed production of IL-2 observed in the postoperative period in our present and previous studies 6 are in agreement with reports of alterations in cytokine serum levels following surgery (e.g.  , Baxevanis et al.  7).
Surgery-associated tissue injury sets off a cascade of related events, including nociception and inflammatory reaction. Tissue and peripheral nerve injury leads to local inflammatory reaction, accompanied by elevated levels of proinflammatory cytokines, including IL-1β and IL-6. 8 These cytokines can induce peripheral and central nerve system sensitization, leading to pain augmentation (hyperalgesia). 8 Peripherally, IL-1β induces long-lasting synthesis and release of substance P from peripheral nerve terminals of primary afferent neurons, which may contribute to neurogenic inflammation. 9,10 
Within minutes of injury, glial cells in the central nervous system respond with increased production of immune factors, including proinflammatory cytokines. 11 IL-1β can induce central sensitization via  IL-1 receptors on neurons 12 or via  activated glia cells, which produce pain mediators, including substance P, glutamate, and nitric oxide synthase, 13 all of which can alter pain processing within the central nervous system. Elevated IL-1β in the central nervous system also leads to the production of COX2 by neurons in the brain and spinal cord and further synthesis of PGE2, which is known to increase pain sensitivity. 14 Similarly, IL-6 levels are also elevated following nerve injury, both peripherally and centrally, contributing to hyperalgesia by direct spinal nociceptive mechanisms or by glial activation. 15,16 IL-1β and IL-6 are involved in the mechanisms of allodynia and possibly in the development of postoperative neuropathic and chronic pain. 11,17 
It has been argued that preemptive analgesia, commencing before surgery and continuing in the postoperative period, prevents the establishment of peripheral and central sensitization. 3 In the present study, patients receiving preemptive analgesia exhibited less severe pain and attenuation of proinflammatory cytokine production throughout the postoperative period. It is difficult to determine whether blocking the pain contributes to the reduced production of proinflammatory cytokines or, vice versa  , reduced production of proinflammatory cytokines results in less severe pain experience.
It is noteworthy that patients receiving preemptive analgesia also exhibited less suppression of IL-2 production in the postoperative period. Since IL-2 is secreted by the TH1 subset of lymphocytes, the present finding may suggest attenuated suppression of the TH1 phenotypic response in the PA + PCEA pain management group. It has been shown that IL-2 structurally resembles opiate peptides and has analgesic effects in both the peripheral and central nervous system. 18 Thus, it is possible that less suppressed IL-2 levels seen in the PA + PCEA group contributes to the less severe pain reported by these patients.
In conclusion, preemptive analgesia results in reduced pain intensity and attenuated production of proinflammatory cytokines by stimulated PBMCs in the postoperative period. These findings are interrelated, demonstrating correlation between subjective measure of pain and objective measures of immune reactivity. Proinflammatory cytokines are key mediators of illness symptoms, including fever, reduction in synthesis and release of acute phase proteins, deceased food and water intake, and hyperalgesia. This study suggests that reduced secretion of proinflammatory cytokines following preemptive analgesia may contribute to reduced postoperative pain and possibly to attenuated illness response. 19 
References
Kehlet H: Surgical stress: The role of pain and analgesia. Br J Anaesth 1989; 63: 189–95Kehlet, H
Page GG, Blakely WP, Ben-Eliyahu S: Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191–9Page, GG Blakely, WP Ben-Eliyahu, S
Kissin I: Preemptive analgesia. A nesthesiology 2000; 93: 1138–43Kissin, I
Ballantyne J: Pre-emptive analgesia: An unsolved problem. Curr Opin Anaesth 2001; 14: 499–504Ballantyne, J
McClave JT, Dietrich FHII: Statistics, 4th edition. San Francisco, Dellen, 1988, pp: 479–565
Beilin B, Shavit Y, Razumovsky G, Wollach J, Zeidel A, Bessler H: Effects of mild perioperative hypothermia on cellular immune responses. A nesthesiology 1998; 89: 1133–40Beilin, B Shavit, Y Razumovsky, G Wollach, J Zeidel, A Bessler, H
Baxevanis CN, Papilas K, Dedoussis GV, Pavlis T, Papamichail M: Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery. Clin Immunol Immunopath 1994; 71: 82–8Baxevanis, CN Papilas, K Dedoussis, GV Pavlis, T Papamichail, M
Watkins LR, Maier SF, Goehler LE: Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses, and pathological pain states. Pain 1995; 63: 289–302Watkins, LR Maier, SF Goehler, LE
Jeanjean AP, Moussaoui SM, Maloteaux JM, Laduron PM: Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P. Neurosci 1995; 68: 151–7Jeanjean, AP Moussaoui, SM Maloteaux, JM Laduron, PM
Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, Nakata Y: Interleukin-1β induces substance P release from primary afferent neurons through the cyclooxigenase-2 system. J Neurochem 1999; 73: 2206–13Inoue, A Ikoma, K Morioka, N Kumagai, K Hashimoto, T Hide, I Nakata, Y
Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA: Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat. Brain Res 1999; 829: 209–21Sweitzer, SM Colburn, RW Rutkowski, M DeLeo, JA
Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovski HO: A neuromodulatory role of interleukin-1 beta in the hippocampus. Proc Natl Acad Sci U S A 1998; 95: 7778–83Schneider, H Pitossi, F Balschun, D Wagner, A del Rey, A Besedovski, HO
Watkins LR, Milligan ED, Maier SF: Spinal cord glia: New player in pain. Pain 2001; 93: 201–5Watkins, LR Milligan, ED Maier, SF
Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ: Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471–5Samad, TA Moore, KA Sapirstein, A Billet, S Allchorne, A Poole, S Bonventre, JV Woolf, CJ
DeLeo J, Colburn RY, Nichols M, Malhotra A: Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in rat mononeuropathy model. J Interferone Cytok Res 1996; 16: 695–700DeLeo, J Colburn, RY Nichols, M Malhotra, A
Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, Bisby MA: Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 1999; 11: 2243–53Murphy, PG Ramer, MS Borthwick, L Gauldie, J Richardson, PM Bisby, MA
Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B: Possible role of inflammatory mediators in tactile hypersensitivity in rat model of mononeuropathy. Pain 2000; 88: 239–48Cui, JG Holmin, S Mathiesen, T Meyerson, BA Linderoth, B
Jiang CL, Xu D, Lu CL, Wang YX, You ZD, Liu XY: Interleukin-2: Structural and biological relatedness to opioid peptides. Neuroimmunomodul 2000; 8: 20–4Jiang, CL Xu, D Lu, CL Wang, YX You, ZD Liu, XY
Watkins, LR, Maier SF: Illness-induced hyperalgesia: Mediators, mechanisms and implications, Cytokine and Pain. Edited by Watkins LR Maier SF. Basel, Birkhäuser Verlag, 1999, pp 39–57
Fig. 1. Visual analog scale (VAS) pain scores at rest (A  ) and during coughing (B  ) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
Fig. 1. Visual analog scale (VAS) pain scores at rest (A 
	) and during coughing (B 
	) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
Fig. 1. Visual analog scale (VAS) pain scores at rest (A  ) and during coughing (B  ) beginning 4 h and up to 72 h postoperatively, for patients of the two groups: patient-controlled epidural analgesia (PCEA) or preemptive analgesia (PA) plus PCEA. Pain intensity was significantly greater in patients of the PCEA group throughout the observation period, both at rest and during coughing. Values are mean (±SEM).
×
Fig. 2. Production of interleukin (IL)-1β (A  ), IL-6 (B  ), and tumor necrosis factor (TNF) α (C  ) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 2. Production of interleukin (IL)-1β (A 
	), IL-6 (B 
	), and tumor necrosis factor (TNF) α (C 
	) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 2. Production of interleukin (IL)-1β (A  ), IL-6 (B  ), and tumor necrosis factor (TNF) α (C  ) by peripheral blood mononuclear cells in the two study groups. Levels of the proinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Fig. 3. Production of interleukin (IL)-10 (A  ) and IL-1ra (B  ) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 3. Production of interleukin (IL)-10 (A 
	) and IL-1ra (B 
	) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 3. Production of interleukin (IL)-10 (A  ) and IL-1ra (B  ) by peripheral blood mononuclear cells in the two study groups. Levels of the antiinflammatory cytokines were more elevated in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
Fig. 4. Production of interleukin (IL)-2 by peripheral blood mononuclear cells in the two study groups. Levels of IL-2 were more suppressed in the patient-controlled epidural analgesia (PCEA) group. Values are mean (±SEM). PA = preemptive analgesia.
×
Table 1. Characteristics of Patients According to Postoperative Pain Management Group
Image not available
Table 1. Characteristics of Patients According to Postoperative Pain Management Group
×